Clinical Trial Update: Efficacy and Safety of Dabigatran Compared to Warfarin for 6 Month Treatment of Acute Symptomatic Venous Thromboembolism [Phase 3]

View source ↗

Summary

A Phase 3 study comparing dabigatran etexilate with warfarin for six months of treatment in adults with acute symptomatic venous thromboembolism, with results p…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Deep Vein Thrombosis
• Pulmonary Embolism
• Venous Thromboembolism

Drugs mentioned

• Pradaxa (dabigatran etexilate)
• Warfarin (warfarin)

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Thromboembolism | Phase 3 | Status: COMPLETED | Results posted: 2011-02-11